Study S003284

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07658560
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 200
Start: 2026-06-30
Primary completion: 2027-02-28
Lead sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Conditions: Overweight or Obese Participants Without Diabetes
Interventions: DRUG:BGM0504 tablets; DRUG:BGM0504 placebo
Results posted: FALSE

Registered primary outcomes

Fasting body weight [20 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.